NCT04449211 The Effectiveness in the Treatment of Long Bone Defect Using 3D-printed Implant
| NCT ID | NCT04449211 |
| Status | Recruiting |
| Phase | EARLY_Phase 1 |
| Sponsor | Cho Ray Hospital |
| Condition | Bone Loss |
| Study Type | INTERVENTIONAL |
| Enrollment | 10 participants |
| Start Date | 2023-10-06 |
| Primary Completion | 2024-11-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
Phase 1 is the earliest stage of human testing — safety and dosage are the primary focus. Visits are frequent and medical supervision is intensive. You will be among the first people to receive this treatment.
This trial targets 10 participants in total. It began in 2023-10-06 with a primary completion date of 2024-11-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To evaluate the effectiveness of 3D-printed titanium alloy implants in the treatment of long bone defect in adults
Eligibility Criteria
Inclusion Criteria: * Adult participants with health insurance regardless of sex having bone defect greater than 5cm due to trauma or tumour resection agree to participate the research Exclusion Criteria: * Participants with contraindication to surgery * Participants do not agree to undergo surgery * Participants with local infection or soft tissue defect
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04449211 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Bone Loss. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT04449211 trial and what does that mean for participants?
Phase 1 trials are the first stage of human testing. The primary goal is to assess safety and determine appropriate dosage levels. Participants are closely monitored. These trials typically involve a small number of volunteers.
Is NCT04449211 currently recruiting?
Yes, NCT04449211 is actively recruiting participants. Contact the research team at dphungcr@ump.edu.vn for enrollment information.
Where is the NCT04449211 trial being conducted?
This trial is being conducted at Ho Chi Minh City, Vietnam.
Who is sponsoring the NCT04449211 clinical trial?
NCT04449211 is sponsored by Cho Ray Hospital. The trial plans to enroll 10 participants.